TBDPSO
CHO
R1O
i–iii
6
7
OR2
I
8 R1 = H, R2 = TBDPS
9 R1 = Me, R2 = TBDPS
10 R1 = Me, R2 = H
MeO
vi
iv,v
TMS
R
Fig. 1 Molecular structure of 14.
11 R = CH2OH
12 R = CHO
3 (a) M. Ihara, S. Suzuki, Y. Tokunaga, H. Takeshita and K. Fukumoto,
Chem. Commun., 1996, 1801; (b) M. Ihara, S. Suzuki, Y. Tokunaga and
K. Fukumoto, J. Chem. Soc., Perkin Trans. 1, 1995, 2881.
4 A. Hosomi and H. Sakurai, Tetrahedron Lett., 1976, 1295.
5 G. Majetich, D. Lowery and V. Khetani, Tetrahedron Lett., 1990, 31,
51.
MeO
MeO
vii
H
6 S. V. Ley, J. Norman, W. P. Griffith and S. P Marsden, Synthesis, 1994,
639.
H
OH
O
7 EtAlCl2, AlCl3, SnCl4 and TBDMSOTf were also investigated in these
reactions, however, neither 4 nor 5 was obtained.
14
13
Scheme 2 Reagents and conditions: i, But Li, THF, 278 °C (84%); ii, MeI,
NaH, DMF, 0 °C ? rt (96%); iii, TBAF, THF, rt (94%); iv, BuLi, TMSCI,
TMEDA, THF, 0 °C, then 10% KHSO4 (94%); v, 20 mol% TPAP, NMO,
4 Å molecular sieves, CH2Cl2, rt (77%), vi, TBAF, THF, rt (66%); vii, 20
mol% TPAP, NMO, 4 Å molecular sieves, CH2Cl2, rt (95%).
8 Selected data for 5: dH(300 MHz, CDCl3) 1.17 (s, 3H), 1.35–1.59 (m,
4H), 1.84–1.99 (m, 2H), 2.90–3.01 (m, 1H), 3.11 (dt, J 4.8, 3.2, 1H),
3.79 (dd, J 8.8, 3.2, 1H), 5.25 (ddd, J 11.6, 9.2, 7.6, 1H), 5.31 (d, J 11.6
Hz), 5.71 (ddd, J 9.6, 5.2, 1.6 Hz), 5.81 (dd, J 9.6, 1.6 Hz), 5.83–5.92 (m,
2H); dC (75 MHz, CDCl3) 137.3, 137.2, 136.0, 128.7, 126.0, 123.8,
77.6, 44.5, 40.0, 31.1, 29.6, 25.9, 25.6.
9 D. D. Sternbach and C. L. Ensinger, J. Org. Chem., 1990, 55, 2725.
10 D. Seyferth, J. K. Heeren, G. Singh, S. O. Grim and W. B. Hughes, J.
Organomet. Chem., 1966, 5, 267; G. Stork and K. Zhao, Tetrahedron
Lett., 1989, 30, 2173.
obtained as a single stereoisomer. It is well documented by
Birch that cyclopentadienyl anions react in the middle posi-
tion.13
11 Selected data for 13: dH(300 MHz, CDCl3): 0.79 (s, 3H), 0.93–0.99 (m,
4H), 1.21 (s, 3H), 1.40–1.60 (br s, 1H), 1.98 (dd, J 15.0, 8.8 Hz),
3.08–3.13 (m, 1H), 3.20 and 3.25 (each s, 2.8H and 0.2H), 3.99 (dd, J
8.8, 2.2 Hz), 4.67 (dd, J 9.2, 1.1 Hz), 5.09 (dd, J 12.5, 9.2 Hz), 5.52 (dd,
J 12.5, 1.1 Hz), 5.70–5.90 (m, 4H); m/z 230 (M+ 2 18).
12 Crystal data for 14: C16H22O2, plates, mp 34–35 °C, triclinic, P1, a =
7.641(1), b = 15.890(3), c = 6.3477(9) Å, a = 96.66(1), b =
109.31(1), g = 99.48(1)°, V = 705.3(2) Å3, Z = 2, m = 0.75 cm21, Dc
= 1.169 g cm–3, F000 = 272, T = 150 K, R, Rw = 0.039, 0.038 for
2302 absorption–corrected reflections with I > 3.10 s (I). CCDC
graphic files in .cif format.
In summary, the Hosomi–Sakurai type reaction of 3 and 12
possessing the diallylsilane moiety afforded the bicyclic
compounds 5 and 13 under mild conditions. We thank Dr C.
Kabuto, Instrumental Analysis Center, Faculty of Science,
Tohoku University, for the X-ray analysis of 14.
Notes and references
1 For review: G. I. George, T. T. Chen, I. Ojima and D. M. Vyas, Taxane
Anticancer Agents, American Cancer Society, San Diego. 1995.
2 For a recent total synthesis: K. Morihara, R. Hara, S. Kawahara, T.
Nishimori, N. Nakamura, H. Kusama and I. Kuwajima, J. Am. Chem.
Soc., 1998, 120, 12980 and references therein.
13 A. D. Birch, A. L. Hinde and L. Radom, J. Am. Chem. Soc., 1981, 103,
284 and references therein.
Communication 9/01392J
894
Chem. Commun., 1999, 893–894